Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) schizophrenia
Total score on the PANSS Marder Negative Symptom Factor Scale (NSFS) ≥20
Total score on the PANSS Marder Positive Symptom Factor Scale (PSFS) ≤ 30
Receiving stable antipsychotic therapy for at least 8 weeks prior to screening
Receiving a stable dose of other psychotropic agents for at least 8 weeks prior to screening
Subject has had a stable residence or living arrangement for at least 8 weeks prior to screening and the residence or living arrangement is not anticipated to change for the duration of the study
The subject or subject's legally acceptable representative has provided informed consent.
You may not be if
Current schizoaffective or bipolar disorder, panic disorder, obsessive compulsive disorder, evidence of mental retardation by history or clinical examination or known premorbid IQ ≤ 70
Clinically significant suicidal ideation or suicide attempts, assaultive behavior or marked changes in mood within the 8 weeks prior to screening, or currently endorsing suicidal ideation in clinical exam
Substance abuse (with the exception of nicotine or caffeine abuse) within the 8 weeks prior to screening, or during screening
Substance dependence (with the exception of nicotine or caffeine dependence) within the 6 months prior to screening, or during screening
Planning to initiate a smoking cessation therapy or otherwise substantially modify nicotine use during the study
Positive urine drug test for substances of abuse (with the exception of positive screens for prescribed agents such as benzodiazepines).
